Mitsubishi UFJ Trust & Banking Corp Sells 4,635 Shares of Agilent Technologies, Inc. $A

Mitsubishi UFJ Trust & Banking Corp cut its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 3.0% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 152,301 shares of the medical research company’s stock after selling 4,635 shares during the period. Mitsubishi UFJ Trust & Banking Corp owned approximately 0.05% of Agilent Technologies worth $19,548,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. Vanguard Group Inc. boosted its holdings in shares of Agilent Technologies by 1.8% during the 2nd quarter. Vanguard Group Inc. now owns 33,997,845 shares of the medical research company’s stock valued at $4,012,086,000 after acquiring an additional 589,219 shares during the last quarter. Massachusetts Financial Services Co. MA lifted its position in Agilent Technologies by 10.7% during the second quarter. Massachusetts Financial Services Co. MA now owns 13,227,387 shares of the medical research company’s stock valued at $1,560,964,000 after purchasing an additional 1,273,994 shares during the period. Geode Capital Management LLC boosted its holdings in Agilent Technologies by 1.6% in the second quarter. Geode Capital Management LLC now owns 7,319,530 shares of the medical research company’s stock worth $860,137,000 after purchasing an additional 115,183 shares during the last quarter. Generation Investment Management LLP grew its position in Agilent Technologies by 15.9% in the 2nd quarter. Generation Investment Management LLP now owns 5,775,860 shares of the medical research company’s stock worth $681,609,000 after purchasing an additional 792,304 shares during the period. Finally, Norges Bank purchased a new stake in Agilent Technologies during the 2nd quarter valued at $395,088,000.

Insider Transactions at Agilent Technologies

In other news, VP Rodney Gonsalves sold 3,000 shares of the company’s stock in a transaction dated Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total value of $464,970.00. Following the completion of the transaction, the vice president owned 31,846 shares of the company’s stock, valued at $4,935,811.54. This represents a 8.61% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO Padraig Mcdonnell sold 12,490 shares of the business’s stock in a transaction that occurred on Wednesday, November 12th. The stock was sold at an average price of $150.00, for a total value of $1,873,500.00. Following the completion of the transaction, the chief executive officer directly owned 33,448 shares in the company, valued at approximately $5,017,200. This represents a 27.19% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 16,401 shares of company stock valued at $2,468,962.

Agilent Technologies Trading Up 0.5%

Shares of NYSE:A opened at $135.76 on Tuesday. The stock has a 50 day moving average of $143.19 and a 200 day moving average of $134.22. The company has a market cap of $38.49 billion, a PE ratio of 29.71, a price-to-earnings-growth ratio of 3.92 and a beta of 1.29. Agilent Technologies, Inc. has a 12-month low of $96.43 and a 12-month high of $160.27. The company has a current ratio of 1.96, a quick ratio of 1.52 and a debt-to-equity ratio of 0.45.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Monday, November 24th. The medical research company reported $1.59 earnings per share for the quarter, beating the consensus estimate of $1.58 by $0.01. The business had revenue of $1.86 billion for the quarter, compared to the consensus estimate of $1.83 billion. Agilent Technologies had a net margin of 18.75% and a return on equity of 25.20%. The company’s revenue for the quarter was up 9.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.46 earnings per share. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. As a group, equities research analysts expect that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 28th. Stockholders of record on Tuesday, January 6th will be given a $0.255 dividend. The ex-dividend date is Tuesday, January 6th. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.25. This represents a $1.02 annualized dividend and a dividend yield of 0.8%. Agilent Technologies’s dividend payout ratio (DPR) is presently 22.32%.

Analyst Ratings Changes

A number of research firms have recently issued reports on A. JPMorgan Chase & Co. raised their price target on Agilent Technologies from $165.00 to $180.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 25th. Rothschild & Co Redburn initiated coverage on Agilent Technologies in a report on Wednesday, October 8th. They issued a “buy” rating and a $165.00 target price on the stock. Barclays upgraded Agilent Technologies from an “equal weight” rating to an “overweight” rating and set a $165.00 price target for the company in a research note on Monday, December 15th. Rothschild Redb upgraded shares of Agilent Technologies to a “strong-buy” rating in a research note on Wednesday, October 8th. Finally, Citigroup raised their price objective on shares of Agilent Technologies from $165.00 to $185.00 and gave the stock a “buy” rating in a report on Tuesday, November 25th. Two analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $164.50.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.